SANUWAVE Health, Inc. (SNWV)
NASDAQ: SNWV · Real-Time Price · USD
33.93
-1.07 (-3.06%)
Oct 17, 2025, 4:00 PM EDT - Market closed
SANUWAVE Health Revenue
SANUWAVE Health had revenue of $10.16M in the quarter ending June 30, 2025, with 41.92% growth. This brings the company's revenue in the last twelve months to $39.19M, up 57.42% year-over-year. In the year 2024, SANUWAVE Health had annual revenue of $32.63M with 59.99% growth.
Revenue (ttm)
$39.19M
Revenue Growth
+57.42%
P/S Ratio
6.21
Revenue / Employee
$852,000
Employees
46
Market Cap
290.71M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 32.63M | 12.24M | 59.99% |
| Dec 31, 2023 | 20.40M | 3.66M | 21.84% |
| Dec 31, 2022 | 16.74M | 3.73M | 28.69% |
| Dec 31, 2021 | 13.01M | 8.95M | 220.68% |
| Dec 31, 2020 | 4.06M | 3.03M | 294.37% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
SNWV News
- 12 days ago - Aehr Test Systems Posts Q1 Earnings, Joins SANUWAVE Health And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga
- 13 days ago - SANUWAVE Health, Inc. (SNWV) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 13 days ago - Sanuwave Health Announces Preliminary Revenue Results for the Third Quarter 2025 (Ended September 30, 2025) - GlobeNewsWire
- 23 days ago - Sanuwave Announces Strategic Debt Refinancing with New Credit Facility - GlobeNewsWire
- 4 weeks ago - Sanuwave: A Long-Term Compounder In Its Early Stages - Seeking Alpha
- 2 months ago - SANUWAVE Health, Inc. (SNWV) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Sanuwave Announces Q2 FY2025 Financial Results - GlobeNewsWire
- 2 months ago - Sanuwave Will Host a Conference Call on August 8, 2025 at 8:30 AM (ET) to Present Q2 2025 Financial Results - GlobeNewsWire